{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:26:29Z","timestamp":1793906789153,"version":"4.8.0"},"reference-count":254,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1038\/s41574-022-00682-7","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T16:04:46Z","timestamp":1652717086000},"page":"473-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Skeletal and extraskeletal disorders of biomineralization"],"prefix":"10.1038","volume":"18","author":[{"given":"Michael T.","family":"Collins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-2956","authenticated-orcid":false,"given":"Hans-Joachim","family":"Anders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Beltrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0752-4408","authenticated-orcid":false,"given":"Jane A.","family":"Cauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Ebeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3497-3057","authenticated-orcid":false,"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3455-002X","authenticated-orcid":false,"given":"Agn\u00e8s","family":"Linglart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sangiorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2107-7923","authenticated-orcid":false,"given":"Dwight A.","family":"Towler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8316-0728","authenticated-orcid":false,"given":"Ria","family":"Weston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael. P.","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3801-9546","authenticated-orcid":false,"given":"Bart","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-3220","authenticated-orcid":false,"given":"Rajesh V.","family":"Thakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"682_CR1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-021-00477-2","volume":"17","author":"A Arnold","year":"2021","unstructured":"Arnold, A. et al. Hormonal regulation of biomineralization. Nat. Rev. Endocrinol. 17, 261\u2013275 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"682_CR2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00418-018-1646-0","volume":"149","author":"T Hasegawa","year":"2018","unstructured":"Hasegawa, T. Ultrastructure and biological function of matrix vesicles in bone mineralization. Histochem. Cell Biol. 149, 289\u2013304 (2018).","journal-title":"Histochem. Cell Biol."},{"key":"682_CR3","doi-asserted-by":"crossref","first-page":"204173141881013","DOI":"10.1177\/2041731418810130","volume":"9","author":"I Azoidis","year":"2018","unstructured":"Azoidis, I., Cox, S. C. & Davies, O. G. The role of extracellular vesicles in biomineralisation: current perspective and application in regenerative medicine. J. Tissue Eng. 9, 2041731418810130 (2018).","journal-title":"J. Tissue Eng."},{"key":"682_CR4","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.bbagen.2009.09.006","volume":"1790","author":"EE Golub","year":"2009","unstructured":"Golub, E. E. Role of matrix vesicles in biomineralization. Biochim. Biophys. Acta 1790, 1592\u20131598 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"682_CR5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1272\/jnms.77.4","volume":"77","author":"H Orimo","year":"2010","unstructured":"Orimo, H. The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J. Nippon Med. Sch. 77, 4\u201312 (2010).","journal-title":"J. Nippon Med. Sch."},{"key":"682_CR6","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1073\/pnas.67.3.1513","volume":"67","author":"SY Ali","year":"1970","unstructured":"Ali, S. Y., Sajdera, S. W. & Anderson, H. C. Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage. Proc. Natl Acad. Sci. USA 67, 1513\u20131520 (1970).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"682_CR7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0169-6009(92)90877-G","volume":"19","author":"DC Morris","year":"1992","unstructured":"Morris, D. C., Masuhara, K., Takaoka, K., Ono, K. & Anderson, H. C. Immunolocalization of alkaline phosphatase in osteoblasts and matrix vesicles of human fetal bone. Bone Min. 19, 287\u2013298 (1992).","journal-title":"Bone Min."},{"key":"682_CR8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/BCO.0b013e3282e9ab49","volume":"18","author":"HC Anderson","year":"2007","unstructured":"Anderson, H. C. The role of matrix vesicles in physiological and pathological calcification. Curr. Opin. Orthop. 18, 428\u2013433 (2007).","journal-title":"Curr. Opin. Orthop."},{"key":"682_CR9","first-page":"266","volume":"314","author":"HC Anderson","year":"1995","unstructured":"Anderson, H. C. Molecular biology of matrix vesicles. Clin. Orthop. Relat. Res. 314, 266\u2013280 (1995).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"682_CR10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.steroids.2017.12.003","volume":"142","author":"N Asmussen","year":"2019","unstructured":"Asmussen, N., Lin, Z., McClure, M. J., Schwartz, Z. & Boyan, B. D. Regulation of extracellular matrix vesicles via rapid responses to steroid hormones during endochondral bone formation. Steroids 142, 43\u201347 (2019).","journal-title":"Steroids"},{"key":"682_CR11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2015.05.013","volume":"79","author":"IM Shapiro","year":"2015","unstructured":"Shapiro, I. M., Landis, W. J. & Risbud, M. V. Matrix vesicles: are they anchored exosomes? Bone 79, 29\u201336 (2015).","journal-title":"Bone"},{"key":"682_CR12","doi-asserted-by":"crossref","first-page":"9417914","DOI":"10.1155\/2019\/9417914","volume":"2019","author":"C Masaoutis","year":"2019","unstructured":"Masaoutis, C. & Theocharis, S. The role of exosomes in bone remodeling: implications for bone physiology and disease. Dis. Markers 2019, 9417914 (2019).","journal-title":"Dis. Markers"},{"key":"682_CR13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2741\/3918","volume":"17","author":"E Bonucci","year":"2012","unstructured":"Bonucci, E. Bone mineralization. Front. Biosci. 17, 100\u2013128 (2012).","journal-title":"Front. Biosci."},{"key":"682_CR14","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.18388\/abp.2003_3629","volume":"50","author":"M Balcerzak","year":"2003","unstructured":"Balcerzak, M. et al. The roles of annexins and alkaline phosphatase in mineralization process. Acta Biochim. Pol. 50, 1019\u20131038 (2003).","journal-title":"Acta Biochim. Pol."},{"key":"682_CR15","doi-asserted-by":"crossref","first-page":"35577","DOI":"10.1074\/jbc.M005648200","volume":"275","author":"T Kirsch","year":"2000","unstructured":"Kirsch, T., Harrison, G., Golub, E. E. & Nah, H. D. The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage. J. Biol. Chem. 275, 35577\u201335583 (2000).","journal-title":"J. Biol. Chem."},{"key":"682_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S8756-3282(00)00302-1","volume":"27","author":"J Guicheux","year":"2000","unstructured":"Guicheux, J. et al. A novel in vitro culture system for analysis of functional role of phosphate transport in endochondral ossification. Bone 27, 69\u201374 (2000).","journal-title":"Bone"},{"key":"682_CR17","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/MCB.00104-07","volume":"27","author":"Y Yoshiko","year":"2007","unstructured":"Yoshiko, Y., Candeliere, G. A., Maeda, N. & Aubin, J. E. Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Mol. Cell Biol. 27, 4465\u20134474 (2007).","journal-title":"Mol. Cell Biol."},{"key":"682_CR18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00223-012-9672-8","volume":"93","author":"JL Millan","year":"2013","unstructured":"Millan, J. L. The role of phosphatases in the initiation of skeletal mineralization. Calcif. Tissue Int. 93, 299\u2013306 (2013).","journal-title":"Calcif. Tissue Int."},{"key":"682_CR19","doi-asserted-by":"crossref","first-page":"15872","DOI":"10.1074\/jbc.M701116200","volume":"282","author":"WN Addison","year":"2007","unstructured":"Addison, W. N., Azari, F., Sorensen, E. S., Kaartinen, M. T. & McKee, M. D. Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J. Biol. Chem. 282, 15872\u201315883 (2007).","journal-title":"J. Biol. Chem."},{"key":"682_CR20","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.2001.281.1.C1","volume":"281","author":"RA Terkeltaub","year":"2001","unstructured":"Terkeltaub, R. A. Inorganic pyrophosphate generation and disposition in pathophysiology. Am. J. Physiol. Cell Physiol. 281, C1\u2013C11 (2001).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"682_CR21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00223-012-9690-6","volume":"93","author":"L Brylka","year":"2013","unstructured":"Brylka, L. & Jahnen-Dechent, W. The role of fetuin-A in physiological and pathological mineralization. Calcif. Tissue Int. 93, 355\u2013364 (2013).","journal-title":"Calcif. Tissue Int."},{"key":"682_CR22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2015.05.046","volume":"82","author":"ML Zoch","year":"2016","unstructured":"Zoch, M. L., Clemens, T. L. & Riddle, R. C. New insights into the biology of osteocalcin. Bone 82, 42\u201349 (2016).","journal-title":"Bone"},{"key":"682_CR23","doi-asserted-by":"crossref","unstructured":"Grynpas, M. D., Chachra, D. & Limeback, H. in The Osteoporosis Primer Vol. 23 318-330 (Cambridge University Press, 2000).","DOI":"10.1017\/CBO9780511545795.024"},{"key":"682_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/8756-3282(89)90004-5","volume":"10","author":"G Boivin","year":"1989","unstructured":"Boivin, G., Chavassieux, P., Chapuy, M. C., Baud, C. A. & Meunier, P. J. Skeletal fluorosis: histomorphometric analysis of bone changes and bone fluoride content in 29 patients. Bone 10, 89\u201399 (1989).","journal-title":"Bone"},{"issue":"Suppl. 1","key":"682_CR25","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1002\/jbmr.5650051362","volume":"5","author":"MD Grynpas","year":"1990","unstructured":"Grynpas, M. D. Fluoride effects on bone crystals. J. Bone Min. Res. 5 (Suppl. 1), S169\u2013S175 (1990).","journal-title":"J. Bone Min. Res."},{"issue":"Suppl. 1","key":"682_CR26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000260299","volume":"11","author":"EC Moreno","year":"1977","unstructured":"Moreno, E. C., Kresak, M. & Zahradnik, R. T. Physicochemical aspects of fluoride-apatite systems relevant to the study of dental caries. Caries Res. 11 (Suppl. 1), 142\u2013171 (1977).","journal-title":"Caries Res."},{"key":"682_CR27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02553291","volume":"39","author":"MD Grynpas","year":"1986","unstructured":"Grynpas, M. D., Patterson-Allen, P. & Simmons, D. J. The changes in quality of mandibular bone mineral in otherwise totally immobilized rhesus monkeys. Calcif. Tissue Int. 39, 57\u201362 (1986).","journal-title":"Calcif. Tissue Int."},{"key":"682_CR28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/er.2006-0029","volume":"28","author":"P Chavassieux","year":"2007","unstructured":"Chavassieux, P., Seeman, E. & Delmas, P. D. Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease. Endocr. Rev. 28, 151\u2013164 (2007).","journal-title":"Endocr. Rev."},{"key":"682_CR29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte, M. P. Hypophosphatasia-aetiology, nosology, pathogenesis, diagnosis and treatment. Nat. Rev. Endocrinol. 12, 233\u2013246 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"682_CR30","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1073\/pnas.85.20.7666","volume":"85","author":"MJ Weiss","year":"1988","unstructured":"Weiss, M. J. et al. A missense mutation in the human liver\/bone\/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc. Natl Acad. Sci. USA 85, 7666\u20137669 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"682_CR31","doi-asserted-by":"crossref","first-page":"12002","DOI":"10.1016\/S0021-9258(18)37885-2","volume":"263","author":"MJ Weiss","year":"1988","unstructured":"Weiss, M. J. et al. Structure of the human liver\/bone\/kidney alkaline phosphatase gene. J. Biol. Chem. 263, 12002\u201312010 (1988).","journal-title":"J. Biol. Chem."},{"key":"682_CR32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","volume":"98","author":"JL Millan","year":"2016","unstructured":"Millan, J. L. & Whyte, M. P. Alkaline phosphatase and hypophosphatasia. Calcif. Tissue Int. 98, 398\u2013416 (2016).","journal-title":"Calcif. Tissue Int."},{"key":"682_CR33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jbmr.3075","volume":"32","author":"MP Whyte","year":"2017","unstructured":"Whyte, M. P. Hypophosphatasia: enzyme replacement therapy brings new opportunities and new challenges. J. Bone Min. Res. 32, 667\u2013675 (2017).","journal-title":"J. Bone Min. Res."},{"key":"682_CR34","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85971","volume":"1","author":"MP Whyte","year":"2016","unstructured":"Whyte, M. P. et al. Asfotase alfa therapy for children with hypophosphatasia. JCI Insight 1, e85971 (2016).","journal-title":"JCI Insight"},{"key":"682_CR35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bone.2019.02.025","volume":"122","author":"MP Whyte","year":"2019","unstructured":"Whyte, M. P., McAlister, W. H., Mumm, S. & Bierhals, A. J. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia. Bone 122, 231\u2013236 (2019).","journal-title":"Bone"},{"key":"682_CR36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2213-8587(18)30307-3","volume":"7","author":"MP Whyte","year":"2019","unstructured":"Whyte, M. P. et al. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol. 7, 93\u2013105 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"682_CR37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1098-1004(200004)15:4<309::AID-HUMU2>3.0.CO;2-C","volume":"15","author":"E Mornet","year":"2020","unstructured":"Mornet, E. Hypophosphatasia: the mutations in the tissue-nonspecific alkaline phosphatase gene. Hum. Mutat. 15, 309\u2013315 (2020).","journal-title":"Hum. Mutat."},{"key":"682_CR38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","volume":"75","author":"MP Whyte","year":"2015","unstructured":"Whyte, M. P. et al. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25\u00a0years experience with 173 pediatric patients. Bone 75, 229\u2013239 (2015).","journal-title":"Bone"},{"key":"682_CR39","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte, M. P. et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N. Engl. J. Med. 366, 904\u2013913 (2012).","journal-title":"N. Engl. J. Med."},{"key":"682_CR40","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2110","volume":"29","author":"N Guanabens","year":"2014","unstructured":"Guanabens, N. et al. Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters. J. Bone Min. Res. 29, 929\u2013934 (2014).","journal-title":"J. Bone Min. Res."},{"key":"682_CR41","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4158\/EP15890.OR","volume":"22","author":"PM Camacho","year":"2016","unstructured":"Camacho, P. M. et al. Adult hypophosphatasia treated with teriparatide: report of 2 patients and review of the literature. Endocr. Pract. 22, 941\u2013950 (2016).","journal-title":"Endocr. Pract."},{"key":"682_CR42","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jbmr.1565","volume":"27","author":"RA Sutton","year":"2012","unstructured":"Sutton, R. A., Mumm, S., Coburn, S. P., Ericson, K. L. & Whyte, M. P. \u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia. J. Bone Min. Res. 27, 987\u2013994 (2012).","journal-title":"J. Bone Min. Res."},{"key":"682_CR43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1542\/peds.11.4.309","volume":"11","author":"EH Sobel","year":"1953","unstructured":"Sobel, E. H., Clark, L. C. Jr, Fox, R. P. & Robinow, M. Rickets, deficiency of alkaline phosphatase activity and premature loss of teeth in childhood. Pediatrics 11, 309\u2013322 (1953).","journal-title":"Pediatrics"},{"key":"682_CR44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ajmg.1320220410","volume":"22","author":"A Ornoy","year":"1985","unstructured":"Ornoy, A., Adomian, G. E. & Rimoin, D. L. Histologic and ultrastructural studies on the mineralization process in hypophosphatasia. Am. J. Med. Genet. 22, 743\u2013758 (1985).","journal-title":"Am. J. Med. Genet."},{"key":"682_CR45","first-page":"1555","volume":"151","author":"HC Anderson","year":"1997","unstructured":"Anderson, H. C., Hsu, H. H., Morris, D. C., Fedde, K. N. & Whyte, M. P. Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am. J. Pathol. 151, 1555\u20131561 (1997).","journal-title":"Am. J. Pathol."},{"key":"682_CR46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00774-018-0957-5","volume":"37","author":"MJ McKenna","year":"2019","unstructured":"McKenna, M. J., Martin-Grace, J., Crowley, R., Twomey, P. J. & Kilbane, M. T. Congenital hypophosphataemia in adults: determinants of bone turnover markers and amelioration of renal phosphate wasting following total parathyroidectomy. J. Bone Min. Metab. 37, 685\u2013693 (2019).","journal-title":"J. Bone Min. Metab."},{"key":"682_CR47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","volume":"15","author":"D Haffner","year":"2019","unstructured":"Haffner, D. et al. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat. Rev. Nephrol. 15, 435\u2013455 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"682_CR48","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s00198-018-4618-2","volume":"29","author":"G Marcucci","year":"2018","unstructured":"Marcucci, G. et al. Phosphate wasting disorders in adults. Osteoporos. Int. 29, 2369\u20132387 (2018).","journal-title":"Osteoporos. Int."},{"key":"682_CR49","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/0004563214521399","volume":"51","author":"P Manghat","year":"2014","unstructured":"Manghat, P., Sodi, R. & Swaminathan, R. Phosphate homeostasis and disorders. Ann. Clin. Biochem. 51, 631\u2013656 (2014).","journal-title":"Ann. Clin. Biochem."},{"key":"682_CR50","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada, T. et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113, 561\u2013568 (2004).","journal-title":"J. Clin. Invest."},{"key":"682_CR51","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s00467-012-2175-z","volume":"27","author":"M Goretti Penido","year":"2012","unstructured":"Goretti Penido, M. & Alon, U. S. Phosphate homeostasis and its role in bone health. Pediatr. Nephrol. 27, 2039\u20132048 (2012).","journal-title":"Pediatr. Nephrol."},{"key":"682_CR52","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00774-009-0079-1","volume":"27","author":"D Tiosano","year":"2009","unstructured":"Tiosano, D. & Hochberg, Z. Hypophosphatemia: the common denominator of all rickets. J. Bone Min. Metab. 27, 392\u2013401 (2009).","journal-title":"J. Bone Min. Metab."},{"key":"682_CR53","volume":"14","author":"SS Beck-Nielsen","year":"2019","unstructured":"Beck-Nielsen, S. S. et al. FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J. Rare Dis. 14, 58 (2019).","journal-title":"Orphanet J. Rare Dis."},{"key":"682_CR54","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI81928","volume":"126","author":"X Bai","year":"2016","unstructured":"Bai, X. et al. CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders. J. Clin. Invest. 126, 667\u2013680 (2016).","journal-title":"J. Clin. Invest."},{"key":"682_CR55","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-08-0818","volume":"160","author":"SS Beck-Nielsen","year":"2009","unstructured":"Beck-Nielsen, S. S., Brock-Jacobsen, B., Gram, J., Brixen, K. & Jensen, T. K. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur. J. Endocrinol. 160, 491\u2013497 (2009).","journal-title":"Eur. J. Endocrinol."},{"key":"682_CR56","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1210\/endo.142.9.8403","volume":"142","author":"S Liu","year":"2001","unstructured":"Liu, S., Guo, R. & Quarles, L. D. Cloning and characterization of the proximal murine Phex promoter. Endocrinology 142, 3987\u20133995 (2001).","journal-title":"Endocrinology"},{"key":"682_CR57","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/jhg.2015.133","volume":"61","author":"C Weng","year":"2016","unstructured":"Weng, C. et al. A de novo mosaic mutation of PHEX in a boy with hypophosphatemic rickets. J. Hum. Genet. 61, 223\u2013227 (2016).","journal-title":"J. Hum. Genet."},{"key":"682_CR58","first-page":"4075","volume":"81","author":"MP Whyte","year":"1996","unstructured":"Whyte, M. P., Schranck, F. W. & Armamento-Villareal, R. X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children. J. Clin. Endocrinol. Metab. 81, 4075\u20134080 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"682_CR59","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","volume":"3","author":"A Linglart","year":"2014","unstructured":"Linglart, A. et al. Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr. Connect. 3, R13\u2013R30 (2014).","journal-title":"Endocr. Connect."},{"key":"682_CR60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00467-002-1044-6","volume":"18","author":"US Alon","year":"2003","unstructured":"Alon, U. S. et al. Hypertension in hypophosphatemic rickets \u2014 role of secondary hyperparathyroidism. Pediatr. Nephrol. 18, 155\u2013158 (2003).","journal-title":"Pediatr. Nephrol."},{"key":"682_CR61","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jbmr.1766","volume":"28","author":"NM Barros","year":"2013","unstructured":"Barros, N. M. et al. Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia. J. Bone Min. Res. 28, 688\u2013699 (2013).","journal-title":"J. Bone Min. Res."},{"key":"682_CR62","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jbmr.110","volume":"25","author":"WN Addison","year":"2010","unstructured":"Addison, W. N., Masica, D. L., Gray, J. J. & McKee, M. D. Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. J. Bone Min. Res. 25, 695\u2013705 (2010).","journal-title":"J. Bone Min. Res."},{"key":"682_CR63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/SCS.0b013e31819b9868","volume":"20","author":"AS Murthy","year":"2009","unstructured":"Murthy, A. S. X-linked hypophosphatemic rickets and craniosynostosis. J. Craniofac Surg. 20, 439\u2013442 (2009).","journal-title":"J. Craniofac Surg."},{"key":"682_CR64","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00467-010-1705-9","volume":"26","author":"M Zivicnjak","year":"2011","unstructured":"Zivicnjak, M. et al. Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets. Pediatr. Nephrol. 26, 223\u2013231 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"682_CR65","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter, T. O., Imel, E. A., Holm, I. A., Jan de Beur, S. M. & Insogna, K. L. A clinician\u2019s guide to X-linked hypophosphatemia. J. Bone Min. Res. 26, 1381\u20131388 (2011).","journal-title":"J. Bone Min. Res."},{"key":"682_CR66","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-3476(05)82822-7","volume":"116","author":"S Balsan","year":"1990","unstructured":"Balsan, S. & Tieder, M. Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height. J. Pediatr. 116, 365\u2013371 (1990).","journal-title":"J. Pediatr."},{"key":"682_CR67","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1067\/mpd.2003.119","volume":"142","author":"C Chaussain-Miller","year":"2003","unstructured":"Chaussain-Miller, C. et al. Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets: prevention by early treatment with 1-hydroxyvitamin D. J. Pediatr. 142, 324\u2013331 (2003).","journal-title":"J. Pediatr."},{"key":"682_CR68","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/0022034516677528","volume":"96","author":"M Biosse Duplan","year":"2017","unstructured":"Biosse Duplan, M. et al. Phosphate and vitamin D prevent periodontitis in X-linked hypophosphatemia. J. Dent. Res. 96, 388\u2013395 (2017).","journal-title":"J. Dent. Res."},{"key":"682_CR69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bone.2016.11.019","volume":"95","author":"T Boukpessi","year":"2017","unstructured":"Boukpessi, T. et al. Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia. Bone 95, 151\u2013161 (2017).","journal-title":"Bone"},{"key":"682_CR70","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/EJE-15-0661","volume":"174","author":"H Che","year":"2016","unstructured":"Che, H. et al. Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms. Eur. J. Endocrinol. 174, 325\u2013333 (2016).","journal-title":"Eur. J. Endocrinol."},{"key":"682_CR71","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3389\/fcell.2020.00854","volume":"8","author":"CA Faraji-Bellee","year":"2020","unstructured":"Faraji-Bellee, C. A. et al. Development of enthesopathies and joint structural damage in a murine model of X-linked hypophosphatemia. Front. Cell Dev. Biol. 8, 854 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"682_CR72","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4158\/EP12184.CR","volume":"19","author":"GE Sun","year":"2013","unstructured":"Sun, G. E., Suer, O., Carpenter, T. O., Tan, C. D. & Li-Ng, M. Heart failure in hypophosphatemic rickets: complications from high-dose phosphate therapy. Endocr. Pract. 19, e8\u2013e11 (2013).","journal-title":"Endocr. Pract."},{"key":"682_CR73","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00247-007-0503-4","volume":"37","author":"G Currarino","year":"2007","unstructured":"Currarino, G. Sagittal synostosis in X-linked hypophosphatemic rickets and related diseases. Pediatr. Radiol. 37, 805\u2013812 (2007).","journal-title":"Pediatr. Radiol."},{"key":"682_CR74","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000334941","volume":"2","author":"LR Glass","year":"2011","unstructured":"Glass, L. R., Dagi, T. F. & Dagi, L. R. Papilledema in the setting of x-linked hypophosphatemic rickets with craniosynostosis. Case Rep. Ophthalmol. 2, 376\u2013381 (2011).","journal-title":"Case Rep. Ophthalmol."},{"key":"682_CR75","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/jbmr.3614","volume":"34","author":"A Rothenbuhler","year":"2019","unstructured":"Rothenbuhler, A. et al. High incidence of cranial synostosis and Chiari I malformation in children with X-linked hypophosphatemic rickets (XLHR). J. Bone Min. Res. 34, 490\u2013496 (2019).","journal-title":"J. Bone Min. Res."},{"key":"682_CR76","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1210\/jcem.86.8.7730","volume":"86","author":"PT Christie","year":"2001","unstructured":"Christie, P. T., Harding, B., Nesbit, M. A., Whyte, M. P. & Thakker, R. V. X-linked hypophosphatemia attributable to pseudoexons of the PHEX gene. J. Clin. Endocrinol. Metab. 86, 3840\u20133844 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"682_CR77","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI111900","volume":"75","author":"RM Harrell","year":"1985","unstructured":"Harrell, R. M., Lyles, K. W., Harrelson, J. M., Friedman, N. E. & Drezner, M. K. Healing of bone disease in X-linked hypophosphatemic rickets\/osteomalacia. Induction and maintenance with phosphorus and calcitriol. J. Clin. Invest. 75, 1858\u20131868 (1985).","journal-title":"J. Clin. Invest."},{"key":"682_CR78","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","volume":"393","author":"EA Imel","year":"2019","unstructured":"Imel, E. A. et al. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet 393, 2416\u20132427 (2019).","journal-title":"Lancet"},{"key":"682_CR79","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1210\/er.2017-00220","volume":"39","author":"Y Kinoshita","year":"2018","unstructured":"Kinoshita, Y. & Fukumoto, S. X-Linked Hypophosphatemia and FGF23-Related hypophosphatemic diseases: prospect for new treatment. Endocr. Rev. 39, 274\u2013291 (2018).","journal-title":"Endocr. Rev."},{"key":"682_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004447.pub2","author":"Y Huiming","year":"2005","unstructured":"Huiming, Y. & Chaomin, W. Recombinant growth hormone therapy for X-linked hypophosphatemia in children. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD004447.pub2 (2005).","journal-title":"Cochrane Database Syst. Rev."},{"key":"682_CR81","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/jbmr.3992","volume":"35","author":"AL Lecoq","year":"2020","unstructured":"Lecoq, A. L. et al. Hyperparathyroidism in Patients With X-Linked Hypophosphatemia. J. Bone Miner. Res. 35, 1263\u20131273 (2020).","journal-title":"J. Bone Miner. Res."},{"key":"682_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00774-011-0340-2","volume":"30","author":"TO Carpenter","year":"2012","unstructured":"Carpenter, T. O. The expanding family of hypophosphatemic syndromes. J. Bone Min. Metab. 30, 1\u20139 (2012).","journal-title":"J. Bone Min. Metab."},{"key":"682_CR83","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem.82.2.3765","volume":"82","author":"MJ Econs","year":"1997","unstructured":"Econs, M. J. & McEnery, P. T. Autosomal dominant hypophosphatemic rickets\/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J. Clin. Endocrinol. Metab. 82, 674\u2013681 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"682_CR84","volume":"3","author":"EA Imel","year":"2019","unstructured":"Imel, E. A., Biggin, A., Schindeler, A. & Munns, C. F. FGF23, hypophosphatemia, and emerging treatments. JBMR Plus 3, e10190 (2019).","journal-title":"JBMR Plus"},{"key":"682_CR85","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","volume":"96","author":"EA Imel","year":"2011","unstructured":"Imel, E. A. et al. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. J. Clin. Endocrinol. Metab. 96, 3541\u20133549 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"682_CR86","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng1221","volume":"34","author":"F Rutsch","year":"2003","unstructured":"Rutsch, F. et al. Mutations in ENPP1 are associated with \u2018idiopathic\u2019 infantile arterial calcification. Nat. Genet. 34, 379\u2013381 (2003).","journal-title":"Nat. Genet."},{"key":"682_CR87","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajhg.2010.01.010","volume":"86","author":"V Levy-Litan","year":"2010","unstructured":"Levy-Litan, V. et al. Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am. J. Hum. Genet. 86, 273\u2013278 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"682_CR88","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00431-010-1382-5","volume":"170","author":"US Alon","year":"2011","unstructured":"Alon, U. S. Clinical practice. Fibroblast growth factor (FGF)23: a new hormone. Eur. J. Pediatr. 170, 545\u2013554 (2011).","journal-title":"Eur. J. Pediatr."},{"key":"682_CR89","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/jbmr.3683","volume":"34","author":"T Liu","year":"2019","unstructured":"Liu, T. et al. DMP1 ablation in the rabbit results in mineralization defects and abnormalities in Haversian canal\/osteon microarchitecture. J. Bone Min. Res. 34, 1115\u20131128 (2019).","journal-title":"J. Bone Min. Res."},{"key":"682_CR90","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41436-020-00983-0","volume":"23","author":"CR Ferreira","year":"2021","unstructured":"Ferreira, C. R. et al. Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI). Genet. Med. 23, 396\u2013407 (2021).","journal-title":"Genet. Med."},{"key":"682_CR91","doi-asserted-by":"crossref","first-page":"F371","DOI":"10.1152\/ajprenal.00090.2008","volume":"295","author":"G Jaureguiberry","year":"2008","unstructured":"Jaureguiberry, G., Carpenter, T. O., Forman, S., Juppner, H. & Bergwitz, C. A novel missense mutation in SLC34A3 that causes hereditary hypophosphatemic rickets with hypercalciuria in humans identifies threonine 137 as an important determinant of sodium-phosphate cotransport in NaPi-IIc. Am. J. Physiol. Ren. Physiol. 295, F371\u2013F379 (2008).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"682_CR92","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/499410","volume":"78","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux, B. et al. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am. J. Hum. Genet. 78, 193\u2013201 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"682_CR93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00424-018-2184-2","volume":"471","author":"C Bergwitz","year":"2019","unstructured":"Bergwitz, C. & Miyamoto, K. I. Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy. Pflug. Arch. 471, 149\u2013163 (2019).","journal-title":"Pflug. Arch."},{"key":"682_CR94","doi-asserted-by":"crossref","first-page":"C1316","DOI":"10.1152\/ajpcell.00314.2011","volume":"302","author":"S Haito-Sugino","year":"2012","unstructured":"Haito-Sugino, S. et al. Processing and stability of type IIc sodium-dependent phosphate cotransporter mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria. Am. J. Physiol. Cell Physiol. 302, C1316\u2013C1330 (2012).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"682_CR95","first-page":"473","volume":"87","author":"OM Wrong","year":"1994","unstructured":"Wrong, O. M., Norden, A. G. & Feest, T. G. Dent\u2019s disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87, 473\u2013493 (1994).","journal-title":"QJM"},{"key":"682_CR96","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-5-28","volume":"5","author":"O Devuyst","year":"2010","unstructured":"Devuyst, O. & Thakker, R. V. Dent\u2019s disease. Orphanet J. Rare Dis. 5, 28 (2010).","journal-title":"Orphanet J. Rare Dis."},{"key":"682_CR97","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/427887","volume":"76","author":"RR Hoopes Jr.","year":"2005","unstructured":"Hoopes, R. R. Jr. et al. Dent disease with mutations in OCRL1. Am. J. Hum. Genet. 76, 260\u2013267 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"682_CR98","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","volume":"108","author":"P Florenzano","year":"2021","unstructured":"Florenzano, P. et al. Tumor-induced osteomalacia. Calcif. Tissue Int. 108, 128\u2013142 (2021).","journal-title":"Calcif. Tissue Int."},{"key":"682_CR99","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","volume":"29","author":"JC Lee","year":"2016","unstructured":"Lee, J. C. et al. Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors. Mod. Pathol. 29, 1335\u20131346 (2016).","journal-title":"Mod. Pathol."},{"key":"682_CR100","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1507\/endocrj.EJ15-0275","volume":"62","author":"I Endo","year":"2015","unstructured":"Endo, I. et al. Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment. Endocr. J. 62, 811\u2013816 (2015).","journal-title":"Endocr. J."},{"key":"682_CR101","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","volume":"27","author":"Y Jiang","year":"2012","unstructured":"Jiang, Y. et al. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. J. Bone Min. Res. 27, 1967\u20131975 (2012).","journal-title":"J. Bone Min. Res."},{"key":"682_CR102","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","volume":"3","author":"S Minisola","year":"2017","unstructured":"Minisola, S. et al. Tumour-induced osteomalacia. Nat. Rev. Dis. Prim. 3, 17044 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"682_CR103","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1359\/jbmr.080220","volume":"23","author":"H Wang","year":"2008","unstructured":"Wang, H. et al. Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J. Bone Min. Res. 23, 939\u2013948 (2008).","journal-title":"J. Bone Min. Res."},{"key":"682_CR104","doi-asserted-by":"crossref","first-page":"116064","DOI":"10.1016\/j.bone.2021.116064","volume":"152","author":"ML Brandi","year":"2021","unstructured":"Brandi, M. L. et al. Challenges in the management of tumor-induced osteomalacia (TIO). Bone 152, 116064 (2021).","journal-title":"Bone"},{"key":"682_CR105","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMc2020399","volume":"383","author":"IR Hartley","year":"2020","unstructured":"Hartley, I. R. et al. Targeted FGFR blockade for the treatment of tumor-induced osteomalacia. N. Engl. J. Med. 383, 1387\u20131389 (2020).","journal-title":"N. Engl. J. Med."},{"key":"682_CR106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.09428.x","author":"M Ketteler","year":"2005","unstructured":"Ketteler, M., Gross, M. L. & Ritz, E. Calcification and cardiovascular problems in renal failure. Kidney Int. Suppl. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.09428.x (2005).","journal-title":"Kidney Int. Suppl."},{"key":"682_CR107","unstructured":"Ramnitz, M. S., Gafni, R. I. & Collins, M. T. in GeneReviews Vol. NBK476672 (eds M. P. Adam et al.) (University of Washington, 2018)."},{"key":"682_CR108","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","volume":"36","author":"O Topaz","year":"2004","unstructured":"Topaz, O. et al. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat. Genet 36, 579\u2013581 (2004).","journal-title":"Nat. Genet"},{"key":"682_CR109","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","volume":"14","author":"A Benet-Pages","year":"2005","unstructured":"Benet-Pages, A., Orlik, P., Strom, T. M. & Lorenz-Depiereux, B. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum. Mol. Genet. 14, 385\u2013390 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"682_CR110","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","volume":"117","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa, S. et al. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J. Clin. Invest. 117, 2684\u20132691 (2007).","journal-title":"J. Clin. Invest."},{"key":"682_CR111","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1172\/JCI122004","volume":"128","author":"MS Roberts","year":"2018","unstructured":"Roberts, M. S. et al. Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies. J. Clin. Invest. 128, 5368\u20135373 (2018).","journal-title":"J. Clin. Invest."},{"key":"682_CR112","unstructured":"Ramnitz, M. S., Gafni, R. I. & Collins, M. T. in GeneReviews Vol. NBK476672 (eds M. P. Adam et al.) (University of Washington, 2018)."},{"key":"682_CR113","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/jbmr.2870","volume":"31","author":"MS Ramnitz","year":"2016","unstructured":"Ramnitz, M. S. et al. Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome. J. Bone Min. Res. 31, 1845\u20131854 (2016).","journal-title":"J. Bone Min. Res."},{"key":"682_CR114","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1172\/JCI135665","volume":"130","author":"V Clerin","year":"2020","unstructured":"Clerin, V. et al. Selective pharmacological inhibition of the sodium-dependent phosphate cotransporter NPT2a promotes phosphate excretion. J. Clin. Invest. 130, 6510\u20136522 (2020).","journal-title":"J. Clin. Invest."},{"key":"682_CR115","doi-asserted-by":"crossref","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","volume":"3","author":"M Mannstadt","year":"2017","unstructured":"Mannstadt, M. et al. Hypoparathyroidism. Nat. Rev. Dis. Prim. 3, 17055 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"682_CR116","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1210\/jc.2015-3910","volume":"101","author":"JP Bilezikian","year":"2016","unstructured":"Bilezikian, J. P. et al. Management of hypoparathyroidism: present and future. J. Clin. Endocrinol. Metab. 101, 2313\u20132324 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"682_CR117","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jbmr.3368","volume":"33","author":"L Underbjerg","year":"2018","unstructured":"Underbjerg, L., Sikjaer, T. & Rejnmark, L. Long-term complications in patients with hypoparathyroidism evaluated by biochemical findings: a case-control study. J. Bone Min. Res. 33, 822\u2013831 (2018).","journal-title":"J. Bone Min. Res."},{"key":"682_CR118","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1086\/508069","volume":"79","author":"O Topaz","year":"2006","unstructured":"Topaz, O. et al. A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. Am. J. Hum. Genet. 79, 759\u2013764 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"682_CR119","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fped.2020.00315","volume":"8","author":"MA Levine","year":"2020","unstructured":"Levine, M. A. Diagnosis and management of vitamin D dependent rickets. Front. Pediatr. 8, 315 (2020).","journal-title":"Front. Pediatr."},{"key":"682_CR120","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1365-2036.2012.05093.x","volume":"35","author":"N Gara","year":"2012","unstructured":"Gara, N. et al. Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B. Aliment. Pharmacol. Ther. 35, 1317\u20131325 (2012).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"682_CR121","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1210\/jc.2012-4062","volume":"98","author":"A Grey","year":"2013","unstructured":"Grey, A. et al. Low-dose fluoride in postmenopausal women: a randomized controlled trial. J. Clin. Endocrinol. Metab. 98, 2301\u20132307 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"682_CR122","first-page":"121","volume":"211","author":"SK Jha","year":"2011","unstructured":"Jha, S. K., Mishra, V. K., Sharma, D. K. & Damodaran, T. Fluoride in the environment and its metabolism in humans. Rev. Env. Contam. Toxicol. 211, 121\u2013142 (2011).","journal-title":"Rev. Env. Contam. Toxicol."},{"key":"682_CR123","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10653-013-9592-1","volume":"36","author":"J Chen","year":"2014","unstructured":"Chen, J. et al. Coal utilization in China: environmental impacts and human health. Env. Geochem. Health 36, 735\u2013753 (2014).","journal-title":"Env. Geochem. Health"},{"key":"682_CR124","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0019-557X.92411","volume":"55","author":"KK Majumdar","year":"2011","unstructured":"Majumdar, K. K. Health impact of supplying safe drinking water containing fluoride below permissible level on flourosis patients in a fluoride-endemic rural area of West Bengal. Indian. J. Public Health 55, 303\u2013308 (2011).","journal-title":"Indian. J. Public Health"},{"key":"682_CR125","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bone.2008.07.248","volume":"43","author":"M Mousny","year":"2008","unstructured":"Mousny, M. et al. Fluoride effects on bone formation and mineralization are influenced by genetics. Bone 43, 1067\u20131074 (2008).","journal-title":"Bone"},{"key":"682_CR126","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.etap.2017.09.008","volume":"56","author":"S Pramanik","year":"2017","unstructured":"Pramanik, S. & Saha, D. The genetic influence in fluorosis. Env. Toxicol. Pharmacol. 56, 157\u2013162 (2017).","journal-title":"Env. Toxicol. Pharmacol."},{"key":"682_CR127","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.scitotenv.2006.10.051","volume":"373","author":"MN Tamer","year":"2007","unstructured":"Tamer, M. N. et al. Osteosclerosis due to endemic fluorosis. Sci. Total. Env. 373, 43\u201348 (2007).","journal-title":"Sci. Total. Env."},{"key":"682_CR128","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/tox.21784","volume":"29","author":"J Pei","year":"2014","unstructured":"Pei, J. et al. Fluoride decreased osteoclastic bone resorption through the inhibition of NFATc1 gene expression. Env. Toxicol. 29, 588\u2013595 (2014).","journal-title":"Env. Toxicol."},{"key":"682_CR129","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12011-015-0555-5","volume":"171","author":"Q Liu","year":"2016","unstructured":"Liu, Q. et al. Analysis of the role of insulin signaling in bone turnover induced by fluoride. Biol. Trace Elem. Res. 171, 380\u2013390 (2016).","journal-title":"Biol. Trace Elem. Res."},{"key":"682_CR130","unstructured":"Teotia, S. P. S., Teotia, M., Singh, K. P. & India. in 4th International Workshop on Fluorosis Prevention and Defluoridation of Water (ed. Dahi, E.) (The International Society for Fluoride Research, 2004)."},{"key":"682_CR131","first-page":"ZE05","volume":"9","author":"MR Khairnar","year":"2015","unstructured":"Khairnar, M. R., Dodamani, A. S., Jadhav, H. C., Naik, R. G. & Deshmukh, M. A. Mitigation of fluorosis \u2014 a review. J. Clin. Diagn. Res. 9, ZE05\u2013ZE09 (2015).","journal-title":"J. Clin. Diagn. Res."},{"key":"682_CR132","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1056\/NEJMra1601611","volume":"374","author":"SR Mulay","year":"2016","unstructured":"Mulay, S. R. & Anders, H. J. Crystallopathies. N. Engl. J. Med. 374, 2465\u20132476 (2016).","journal-title":"N. Engl. J. Med."},{"key":"682_CR133","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2019.07.002","volume":"51","author":"LE Munoz","year":"2019","unstructured":"Munoz, L. E. et al. Neutrophil extracellular traps initiate gallstone formation. Immunity 51, 443\u2013450.e444 (2019).","journal-title":"Immunity"},{"key":"682_CR134","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti, F. & Dobson, C. M. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu. Rev. Biochem. 86, 27\u201368 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"682_CR135","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/febs.15174","volume":"287","author":"SR Mulay","year":"2020","unstructured":"Mulay, S. R., Steiger, S., Shi, C. & Anders, H. J. A guide to crystal-related and nano- or microparticle-related tissue responses. FEBS J. 287, 818\u2013832 (2020).","journal-title":"FEBS J."},{"key":"682_CR136","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1189\/jlb.5VMR0415-166R","volume":"98","author":"J Kzhyshkowska","year":"2015","unstructured":"Kzhyshkowska, J. et al. Macrophage responses to implants: prospects for personalized medicine. J. Leukoc. Biol. 98, 953\u2013962 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"682_CR137","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.3390\/ma8095269","volume":"8","author":"Z Sheikh","year":"2015","unstructured":"Sheikh, Z., Brooks, P. J., Barzilay, O., Fine, N. & Glogauer, M. Macrophages, foreign body giant cells and their response to implantable biomaterials. Materials 8, 5671\u20135701 (2015).","journal-title":"Materials"},{"key":"682_CR138","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/tra.12613","volume":"19","author":"F Wang","year":"2018","unstructured":"Wang, F., Gomez-Sintes, R. & Boya, P. Lysosomal membrane permeabilization and cell death. Traffic 19, 918\u2013931 (2018).","journal-title":"Traffic"},{"key":"682_CR139","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-immunol-041015-055539","volume":"34","author":"BS Franklin","year":"2016","unstructured":"Franklin, B. S., Mangan, M. S. & Latz, E. Crystal formation in inflammation. Annu. Rev. Immunol. 34, 173\u2013202 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"682_CR140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"682_CR141","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1681\/ASN.2018121218","volume":"30","author":"SR Mulay","year":"2019","unstructured":"Mulay, S. R. et al. Mitochondria permeability transition versus necroptosis in oxalate-induced AKI. J. Am. Soc. Nephrol. 30, 1857\u20131869 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"682_CR142","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","volume":"20","author":"C Schauer","year":"2014","unstructured":"Schauer, C. et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat. Med. 20, 511\u2013517 (2014).","journal-title":"Nat. Med."},{"key":"682_CR143","volume":"7","author":"J Desai","year":"2017","unstructured":"Desai, J. et al. Particles of different sizes and shapes induce neutrophil necroptosis followed by the release of neutrophil extracellular trap-like chromatin. Sci. Rep. 7, 15003 (2017).","journal-title":"Sci. Rep."},{"key":"682_CR144","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/eji.201545605","volume":"46","author":"J Desai","year":"2016","unstructured":"Desai, J. et al. PMA and crystal-induced neutrophil extracellular trap formation involves RIPK1-RIPK3-MLKL signaling. Eur. J. Immunol. 46, 223\u2013229 (2016).","journal-title":"Eur. J. Immunol."},{"key":"682_CR145","first-page":"e37","volume":"126","author":"C Shi","year":"2020","unstructured":"Shi, C. et al. Crystal clots as therapeutic target in cholesterol crystal embolism. Circ. Res. 126, e37\u2013e52 (2020).","journal-title":"Circ. Res."},{"key":"682_CR146","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrneph.2017.10","volume":"13","author":"SR Mulay","year":"2017","unstructured":"Mulay, S. R. & Anders, H. J. Crystal nephropathies: mechanisms of crystal-induced kidney injury. Nat. Rev. Nephrol. 13, 226\u2013240 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"682_CR147","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1056\/NEJMcp1001011","volume":"363","author":"EM Worcester","year":"2010","unstructured":"Worcester, E. M. & Coe, F. L. Clinical practice. Calcium kidney stones. N. Engl. J. Med. 363, 954\u2013963 (2010).","journal-title":"N. Engl. J. Med."},{"key":"682_CR148","volume":"375","author":"SR Mulay","year":"2016","unstructured":"Mulay, S. R. & Anders, H. J. Crystallopathies. N. Engl. J. Med. 375, e29 (2016).","journal-title":"N. Engl. J. Med."},{"key":"682_CR149","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/JLB.HI0718-249RR","volume":"105","author":"A Mahajan","year":"2019","unstructured":"Mahajan, A. et al. Frontline science: aggregated neutrophil extracellular traps prevent inflammation on the neutrophil-rich ocular surface. J. Leukoc. Biol. 105, 1087\u20131098 (2019).","journal-title":"J. Leukoc. Biol."},{"key":"682_CR150","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1097\/01.ASN.0000099380.18995.F7","volume":"14","author":"M Asselman","year":"2003","unstructured":"Asselman, M., Verhulst, A., De Broe, M. E. & Verkoelen, C. F. Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured\/regenerating tubular epithelial cells in rat kidneys. J. Am. Soc. Nephrol 14, 3155\u20133166 (2003).","journal-title":"J. Am. Soc. Nephrol"},{"key":"682_CR151","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1681\/ASN.2016040486","volume":"28","author":"SR Mulay","year":"2017","unstructured":"Mulay, S. R. et al. Hyperoxaluria requires TNF receptors to initiate crystal adhesion and kidney stone disease. J. Am. Soc. Nephrol. 28, 761\u2013768 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"682_CR152","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJMra1301564","volume":"369","author":"P Cochat","year":"2013","unstructured":"Cochat, P. & Rumsby, G. Primary hyperoxaluria. N. Engl. J. Med. 369, 649\u2013658 (2013).","journal-title":"N. Engl. J. Med."},{"key":"682_CR153","doi-asserted-by":"crossref","first-page":"1903337","DOI":"10.1002\/advs.201903337","volume":"7","author":"A Kletzmayr","year":"2020","unstructured":"Kletzmayr, A. et al. Inhibitors of calcium oxalate crystallization for the treatment of oxalate nephropathies. Adv. Sci. 7, 1903337 (2020).","journal-title":"Adv. Sci."},{"key":"682_CR154","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fimmu.2018.02173","volume":"9","author":"JA Marschner","year":"2018","unstructured":"Marschner, J. A. et al. The long pentraxin PTX3 is an endogenous inhibitor of hyperoxaluria-related nephrocalcinosis and chronic kidney disease. Front. Immunol. 9, 2173 (2018).","journal-title":"Front. Immunol."},{"key":"682_CR155","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3389\/fimmu.2018.00619","volume":"9","author":"S Steiger","year":"2018","unstructured":"Steiger, S. et al. Anti-transforming growth factor beta IgG elicits a dual effect on calcium oxalate crystallization and progressive nephrocalcinosis-related chronic kidney disease. Front. Immunol. 9, 619 (2018).","journal-title":"Front. Immunol."},{"key":"682_CR156","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357\u20131361 (2010).","journal-title":"Nature"},{"key":"682_CR157","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ndt\/gft248","volume":"29","author":"SR Mulay","year":"2014","unstructured":"Mulay, S. R., Evan, A. & Anders, H. J. Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease. Nephrol. Dialysis Transpl. 29, 507\u2013514 (2014).","journal-title":"Nephrol. Dialysis Transpl."},{"key":"682_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010093","author":"SOS Lautenschlager","year":"2019","unstructured":"Lautenschlager, S. O. S. et al. Plasma proteins and platelets modulate neutrophil clearance of malaria-related hemozoin crystals. Cells https:\/\/doi.org\/10.3390\/cells9010093 (2019).","journal-title":"Cells"},{"key":"682_CR159","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.abb.2012.03.003","volume":"523","author":"R Kumar","year":"2012","unstructured":"Kumar, R., Tebben, P. J. & Thompson, J. R. Vitamin D and the kidney. Arch. Biochem. Biophys. 523, 77\u201386 (2012).","journal-title":"Arch. Biochem. Biophys."},{"key":"682_CR160","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2016-1070","volume":"37","author":"PJ Tebben","year":"2016","unstructured":"Tebben, P. J., Singh, R. J. & Kumar, R. Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr. Rev. 37, 521\u2013547 (2016).","journal-title":"Endocr. Rev."},{"key":"682_CR161","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ecl.2017.07.008","volume":"46","author":"L Zand","year":"2017","unstructured":"Zand, L. & Kumar, R. The use of vitamin d metabolites and analogues in the treatment of chronic kidney disease. Endocrinol. Metab. Clin. North. Am. 46, 983\u20131007 (2017).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"682_CR162","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1523-1755.2005.09501.x","volume":"95","author":"J Silver","year":"2005","unstructured":"Silver, J. & Levi, R. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease. Kidney Int. Suppl. 95, S8\u2013S12 (2005).","journal-title":"Kidney Int. Suppl."},{"key":"682_CR163","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5414\/CNP63119","volume":"63","author":"J Silver","year":"2005","unstructured":"Silver, J. & Levi, R. Cellular and molecular mechanisms of secondary hyperparathyroidism. Clin. Nephrol. 63, 119\u2013126 (2005).","journal-title":"Clin. Nephrol."},{"key":"682_CR164","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/sj.ki.5000150","volume":"69","author":"JC Lieske","year":"2006","unstructured":"Lieske, J. C. et al. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 69, 760\u2013764 (2006).","journal-title":"Kidney Int."},{"key":"682_CR165","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ucl.2007.04.003","volume":"34","author":"GC Curhan","year":"2007","unstructured":"Curhan, G. C. Epidemiology of stone disease. Urol. Clin. North. Am. 34, 287\u2013293 (2007).","journal-title":"Urol. Clin. North. Am."},{"key":"682_CR166","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0022-5347(17)35101-7","volume":"151","author":"GC Curhan","year":"1994","unstructured":"Curhan, G. C., Rimm, E. B., Willett, W. C. & Stampfer, M. J. Regional variation in nephrolithiasis incidence and prevalence among United States men. J. Urol. 151, 838\u2013841 (1994).","journal-title":"J. Urol."},{"key":"682_CR167","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ucl.2007.04.009","volume":"34","author":"S Park","year":"2007","unstructured":"Park, S. & Pearle, M. S. Pathophysiology and management of calcium stones. Urol. Clin. North. Am. 34, 323\u2013334 (2007).","journal-title":"Urol. Clin. North. Am."},{"key":"682_CR168","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/jcem-58-1-161","volume":"58","author":"AE Broadus","year":"1984","unstructured":"Broadus, A. E. et al. A consideration of the hormonal basis and phosphate leak hypothesis of absorptive hypercalciuria. J. Clin. Endocrinol. Metab. 58, 161\u2013169 (1984).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"682_CR169","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s005990050069","volume":"29","author":"A Cupisti","year":"1999","unstructured":"Cupisti, A. et al. Serum calcitriol and dietary protein intake in idiopathic calcium stone patients. Int. J. Clin. Lab. Res. 29, 85\u201388 (1999).","journal-title":"Int. J. Clin. Lab. Res."},{"key":"682_CR170","doi-asserted-by":"crossref","first-page":"F1132","DOI":"10.1152\/ajprenal.00296.2013","volume":"305","author":"KK Frick","year":"2013","unstructured":"Frick, K. K. et al. 1,25(OH)(2)D(3)-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet. Am. J. Physiol. Ren. Physiol. 305, F1132\u2013F1138 (2013).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"682_CR171","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/cs0840051","volume":"84","author":"S Giannini","year":"1993","unstructured":"Giannini, S. et al. Possible link between vitamin D and hyperoxaluria in patients with renal stone disease. Clin. Sci. 84, 51\u201354 (1993).","journal-title":"Clin. Sci."},{"key":"682_CR172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137350","volume":"10","author":"H Ketha","year":"2015","unstructured":"Ketha, H. et al. Altered calcium and vitamin D homeostasis in first-time calcium kidney stone-formers. PLoS One 10, e0137350 (2015).","journal-title":"PLoS One"},{"key":"682_CR173","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2215\/CJN.05660614","volume":"9","author":"JC Lieske","year":"2014","unstructured":"Lieske, J. C. et al. Stone composition as a function of age and sex. Clin. J. Am. Soc. Nephrol. 9, 2141\u20132146 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"682_CR174","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.mayocp.2015.07.016","volume":"90","author":"P Singh","year":"2015","unstructured":"Singh, P. et al. Stone composition among first-time symptomatic kidney stone formers in the community. Mayo Clin. Proc. 90, 1356\u20131365 (2015).","journal-title":"Mayo Clin. Proc."},{"key":"682_CR175","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.ki.5000238","volume":"69","author":"A Evan","year":"2006","unstructured":"Evan, A., Lingeman, J., Coe, F. L. & Worcester, E. Randall\u2019s plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int. 69, 1313\u20131318 (2006).","journal-title":"Kidney Int."},{"key":"682_CR176","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI17038","volume":"111","author":"AP Evan","year":"2003","unstructured":"Evan, A. P. et al. Randall\u2019s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J. Clin. Invest. 111, 607\u2013616 (2003).","journal-title":"J. Clin. Invest."},{"key":"682_CR177","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.urology.2013.04.028","volume":"82","author":"AE Krambeck","year":"2013","unstructured":"Krambeck, A. E. et al. Current computed tomography techniques can detect duct of Bellini plugging but not Randall\u2019s plaques. Urology 82, 301\u2013306 (2013).","journal-title":"Urology"},{"key":"682_CR178","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ki.2013.189","volume":"84","author":"MP Linnes","year":"2013","unstructured":"Linnes, M. P. et al. Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification. Kidney Int. 84, 818\u2013825 (2013).","journal-title":"Kidney Int."},{"key":"682_CR179","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.juro.2006.08.088","volume":"177","author":"BR Matlaga","year":"2007","unstructured":"Matlaga, B. R., Coe, F. L., Evan, A. P. & Lingeman, J. E. The role of Randall\u2019s plaques in the pathogenesis of calcium stones. J. Urol. 177, 31\u201338 (2007).","journal-title":"J. Urol."},{"key":"682_CR180","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2215\/CJN.08210813","volume":"9","author":"JC Lieske","year":"2014","unstructured":"Lieske, J. C., Turner, S. T., Edeh, S. N., Smith, J. A. & Kardia, S. L. Heritability of urinary traits that contribute to nephrolithiasis. Clin. J. Am. Soc. Nephrol. 9, 943\u2013950 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"682_CR181","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40620-015-0204-2","volume":"29","author":"JC Lieske","year":"2016","unstructured":"Lieske, J. C. et al. Heritability of dietary traits that contribute to nephrolithiasis in a cohort of adult sibships. J. Nephrol. 29, 45\u201351 (2016).","journal-title":"J. Nephrol."},{"key":"682_CR182","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00240-018-1095-1","volume":"47","author":"JC Lieske","year":"2019","unstructured":"Lieske, J. C. & Wang, X. Heritable traits that contribute to nephrolithiasis. Urolithiasis 47, 5\u201310 (2019).","journal-title":"Urolithiasis"},{"key":"682_CR183","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000369833","volume":"40","author":"T Arcidiacono","year":"2014","unstructured":"Arcidiacono, T. et al. Idiopathic calcium nephrolithiasis: a review of pathogenic mechanisms in the light of genetic studies. Am. J. Nephrol. 40, 499\u2013506 (2014).","journal-title":"Am. J. Nephrol."},{"key":"682_CR184","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/8e7ba8d6-a174-4a3a-93b4-510d5ca7ed1e","volume":"6","author":"DF Gudbjartsson","year":"2010","unstructured":"Gudbjartsson, D. F. et al. Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genet. 6, e1001039 (2010).","journal-title":"PLoS Genet."},{"key":"682_CR185","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13145-x","volume":"10","author":"SA Howles","year":"2019","unstructured":"Howles, S. A. et al. Genetic variants of calcium and vitamin D metabolism in kidney stone disease. Nat. Commun. 10, 5175 (2019).","journal-title":"Nat. Commun."},{"key":"682_CR186","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1359\/jbmr.081245","volume":"24","author":"A Okada","year":"2009","unstructured":"Okada, A. et al. Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of macrophage activity. J. Bone Min. Res. 24, 908\u2013924 (2009).","journal-title":"J. Bone Min. Res."},{"key":"682_CR187","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00240-018-1094-2","volume":"47","author":"R Palsson","year":"2019","unstructured":"Palsson, R., Indridason, O. S., Edvardsson, V. O. & Oddsson, A. Genetics of common complex kidney stone disease: insights from genome-wide association studies. Urolithiasis 47, 11\u201321 (2019).","journal-title":"Urolithiasis"},{"key":"682_CR188","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2350-15-50","volume":"15","author":"N Rungroj","year":"2014","unstructured":"Rungroj, N. et al. A whole genome SNP genotyping by DNA microarray and candidate gene association study for kidney stone disease. BMC Med. Genet. 15, 50 (2014).","journal-title":"BMC Med. Genet."},{"key":"682_CR189","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1681\/ASN.2015111271","volume":"28","author":"K Taguchi","year":"2017","unstructured":"Taguchi, K. et al. Genome-wide gene expression profiling of Randall\u2019s plaques in calcium oxalate stone formers. J. Am. Soc. Nephrol. 28, 333\u2013347 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"682_CR190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.euf.2017.04.010","volume":"3","author":"K Taguchi","year":"2017","unstructured":"Taguchi, K., Yasui, T., Milliner, D. S., Hoppe, B. & Chi, T. Genetic risk factors for idiopathic urolithiasis: a systematic review of the literature and causal network analysis. Eur. Urol. Focus 3, 72\u201381 (2017).","journal-title":"Eur. Urol. Focus"},{"key":"682_CR191","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/ng.404","volume":"41","author":"G Thorleifsson","year":"2009","unstructured":"Thorleifsson, G. et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat. Genet. 41, 926\u2013930 (2009).","journal-title":"Nat. Genet."},{"key":"682_CR192","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002541","volume":"8","author":"Y Urabe","year":"2012","unstructured":"Urabe, Y. et al. A genome-wide association study of nephrolithiasis in the Japanese population identifies novel susceptible Loci at 5q35.3, 7p14.3, and 13q14.1. PLoS Genet. 8, e1002541 (2012).","journal-title":"PLoS Genet."},{"key":"682_CR193","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/ki.2010.430","volume":"80","author":"G Vezzoli","year":"2011","unstructured":"Vezzoli, G., Terranegra, A., Arcidiacono, T. & Soldati, L. Genetics and calcium nephrolithiasis. Kidney Int. 80, 587\u2013593 (2011).","journal-title":"Kidney Int."},{"key":"682_CR194","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1007\/s00198-016-3615-6","volume":"27","author":"DT O\u2019Keeffe","year":"2016","unstructured":"O\u2019Keeffe, D. T. et al. Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect. Osteoporos. Int. 27, 3121\u20133125 (2016).","journal-title":"Osteoporos. Int."},{"key":"682_CR195","doi-asserted-by":"crossref","first-page":"E423","DOI":"10.1210\/jc.2011-1935","volume":"97","author":"PJ Tebben","year":"2012","unstructured":"Tebben, P. J. et al. Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. J. Clin. Endocrinol. Metab. 97, E423\u2013E427 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"682_CR196","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrendo.2012.36","volume":"8","author":"B Thompson","year":"2012","unstructured":"Thompson, B. & Towler, D. A. Arterial calcification and bone physiology: role of the bone-vascular axis. Nat. Rev. Endocrinol. 8, 529\u2013543 (2012).","journal-title":"Nat. Rev. Endocrinol."},{"key":"682_CR197","doi-asserted-by":"crossref","unstructured":"Leibowitz, J. O. The History of Coronary Heart Disease (Wellcome Institute of the History of Medicine, 1970).","DOI":"10.1525\/9780520337688"},{"key":"682_CR198","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCULATIONAHA.116.022562","volume":"135","author":"DA Towler","year":"2017","unstructured":"Towler, D. A. Commonalities between vasculature and bone: an osseocentric view of arteriosclerosis. Circulation 135, 320\u2013322 (2017).","journal-title":"Circulation"},{"key":"682_CR199","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/ATVBAHA.116.306258","volume":"37","author":"JN Stabley","year":"2017","unstructured":"Stabley, J. N. & Towler, D. A. Arterial calcification in diabetes mellitus: preclinical models and translational implications. Arterioscler. Thromb. Vasc. Biol. 37, 205\u2013217 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"682_CR200","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/CIRCRESAHA.108.183053","volume":"104","author":"MY Speer","year":"2009","unstructured":"Speer, M. Y. et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ. Res. 104, 733\u2013741 (2009).","journal-title":"Circ. Res."},{"key":"682_CR201","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","volume":"118","author":"MR Bennett","year":"2016","unstructured":"Bennett, M. R., Sinha, S. & Owens, G. K. Vascular smooth muscle cells in aherosclerosis. Circ. Res. 118, 692\u2013702 (2016).","journal-title":"Circ. Res."},{"key":"682_CR202","doi-asserted-by":"crossref","first-page":"20764","DOI":"10.1073\/pnas.0805133106","volume":"105","author":"L Pederson","year":"2008","unstructured":"Pederson, L., Ruan, M., Westendorf, J. J., Khosla, S. & Oursler, M. J. Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate. Proc. Natl Acad. Sci. USA 105, 20764\u201320769 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"682_CR203","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1182\/blood-2012-06-434621","volume":"121","author":"JA Stefater 3rd","year":"2013","unstructured":"Stefater, J. A. 3rd et al. Macrophage Wnt-Calcineurin-Flt1 signaling regulates mouse wound angiogenesis and repair. Blood 121, 2574\u20132578 (2013).","journal-title":"Blood"},{"key":"682_CR204","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/ATVBAHA.113.302070","volume":"34","author":"LL Demer","year":"2014","unstructured":"Demer, L. L. & Tintut, Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler. Thromb. Vasc. Biol. 34, 715\u2013723 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"682_CR205","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.2337\/db14-0326","volume":"63","author":"SL Cheng","year":"2014","unstructured":"Cheng, S. L. et al. Targeted reduction of vascular Msx1 and Msx2 mitigates arteriosclerotic calcification and aortic stiffness in LDLR-deficient mice fed diabetogenic diets. Diabetes 63, 4326\u20134337 (2014).","journal-title":"Diabetes"},{"key":"682_CR206","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/CIRCRESAHA.112.267237","volume":"111","author":"Y Sun","year":"2012","unstructured":"Sun, Y. et al. Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ. Res. 111, 543\u2013552 (2012).","journal-title":"Circ. Res."},{"key":"682_CR207","volume":"3","author":"S Dillon","year":"2019","unstructured":"Dillon, S., Staines, K. A., Millan, J. L. & Farquharson, C. How to build a bone: PHOSPHO1, biomineralization, and beyond. JBMR 3, e10202 (2019).","journal-title":"JBMR"},{"key":"682_CR208","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1161\/ATVBAHA.120.313792","volume":"40","author":"M Duer","year":"2020","unstructured":"Duer, M., Cobb, A. M. & Shanahan, C. M. DNA damage response: a molecular lynchpin in the pathobiology of arteriosclerotic calcification. Arterioscler. Thromb. Vasc. Biol. 40, e193\u2013e202 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"682_CR209","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrrheum.2017.22","volume":"13","author":"M Croft","year":"2017","unstructured":"Croft, M. & Siegel, R. M. Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases. Nat. Rev. Rheumatol. 13, 217\u2013233 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"682_CR210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/CIRCRESAHA.110.219899","volume":"107","author":"SL Cheng","year":"2010","unstructured":"Cheng, S. L. et al. Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt\/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis. Circ. Res. 107, 271\u2013282 (2010).","journal-title":"Circ. Res."},{"key":"682_CR211","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1474-9726.2010.00616.x","volume":"9","author":"RL Jilka","year":"2010","unstructured":"Jilka, R. L. et al. Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration. Aging Cell 9, 851\u2013867 (2010).","journal-title":"Aging Cell"},{"key":"682_CR212","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCRESAHA.119.316141","volume":"126","author":"A Behrmann","year":"2020","unstructured":"Behrmann, A. et al. PTH\/PTHrP receptor signaling restricts arterial fibrosis in diabetic LDLR(-\/-) mice by inhibiting myocardin-related transcription factor relays. Circ. Res. 126, 1363\u20131378 (2020).","journal-title":"Circ. Res."},{"key":"682_CR213","doi-asserted-by":"crossref","first-page":"F333","DOI":"10.1152\/ajprenal.00503.2012","volume":"305","author":"D Raison","year":"2013","unstructured":"Raison, D. et al. Knockdown of parathyroid hormone related protein in smooth muscle cells alters renal hemodynamics but not blood pressure. Am. J. Physiol. Ren. Physiol. 305, F333\u2013F342 (2013).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"682_CR214","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","volume":"73","author":"N Yu","year":"2010","unstructured":"Yu, N. et al. Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin. Endocrinol. 73, 30\u201334 (2010).","journal-title":"Clin. Endocrinol."},{"key":"682_CR215","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1210\/endo.136.6.7750471","volume":"136","author":"MD Nyby","year":"1995","unstructured":"Nyby, M. D. et al. Desensitization of vascular tissue to parathyroid hormone and parathyroid hormone-related protein. Endocrinology 136, 2497\u20132504 (1995).","journal-title":"Endocrinology"},{"key":"682_CR216","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/HYPERTENSIONAHA.109.134205","volume":"55","author":"JS Shao","year":"2010","unstructured":"Shao, J. S., Cheng, S. L., Sadhu, J. & Towler, D. A. Inflammation and the osteogenic regulation of vascular calcification: a review and perspective. Hypertension 55, 579\u2013592 (2010).","journal-title":"Hypertension"},{"key":"682_CR217","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","volume":"73","author":"KH Zheng","year":"2019","unstructured":"Zheng, K. H. et al. Lipoprotein(a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis. J. Am. Coll. Cardiol. 73, 2150\u20132162 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"682_CR218","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jacc.2010.05.050","volume":"56","author":"S Elmariah","year":"2010","unstructured":"Elmariah, S. et al. Bisphosphonate use and prevalence of valvular and vascular calcification in women MESA (The Multi-Ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol. 56, 1752\u20131759 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"682_CR219","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ccr.2014.07.026","volume":"26","author":"Z Xiang","year":"2014","unstructured":"Xiang, Z. et al. Targeted activation of human Vgamma9Vdelta2-T cells controls Epstein-Barr virus-induced B cell lymphoproliferative disease. Cancer Cell 26, 565\u2013576 (2014).","journal-title":"Cancer Cell"},{"key":"682_CR220","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/jbmr.3448","volume":"33","author":"CW Sing","year":"2018","unstructured":"Sing, C. W. et al. Association of alendronate and risk of cardiovascular events in patients with hip fracture. J. Bone Min. Res. 33, 1422\u20131434 (2018).","journal-title":"J. Bone Min. Res."},{"key":"682_CR221","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag, K. G. et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N. Engl. J. Med. 377, 1417\u20131427 (2017).","journal-title":"N. Engl. J. Med."},{"key":"682_CR222","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1172\/JCI24140","volume":"115","author":"JS Shao","year":"2005","unstructured":"Shao, J. S. et al. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J. Clin. Invest. 115, 1210\u20131220 (2005).","journal-title":"J. Clin. Invest."},{"key":"682_CR223","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/ATVBAHA.116.308723","volume":"37","author":"SM Krishna","year":"2017","unstructured":"Krishna, S. M. et al. Wnt signaling pathway inhibitor sclerostin inhibits angiotensin II-induced aortic aneurysm and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 37, 553\u2013566 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"682_CR224","doi-asserted-by":"crossref","first-page":"dgaa048","DOI":"10.1210\/clinem\/dgaa048","volume":"105","author":"D Shoback","year":"2020","unstructured":"Shoback, D. et al. Pharmacological management of osteoporosis in postmenopausal women: an endocrine society guideline update. J. Clin. Endocrinol. Metab. 105, dgaa048 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"682_CR225","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1172\/JCI6629","volume":"104","author":"B Lanske","year":"1999","unstructured":"Lanske, B. et al. Ablation of the PTHrP gene or the PTH\/PTHrP receptor gene leads to distinct abnormalities in bone development. J. Clin. Invest. 104, 399\u2013407 (1999).","journal-title":"J. Clin. Invest."},{"key":"682_CR226","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211076","volume":"14","author":"JD Gardinier","year":"2019","unstructured":"Gardinier, J. D., Daly-Seiler, C., Rostami, N., Kundal, S. & Zhang, C. Loss of the PTH\/PTHrP receptor along the osteoblast lineage limits the anabolic response to exercise. PLoS One 14, e0211076 (2019).","journal-title":"PLoS One"},{"key":"682_CR227","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bone.2019.05.003","volume":"127","author":"MP Whyte","year":"2019","unstructured":"Whyte, M. P. et al. New explanation for autosomal dominant high bone mass: mutation of low-density lipoprotein receptor-related protein 6. Bone 127, 228\u2013243 (2019).","journal-title":"Bone"},{"key":"682_CR228","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/jbmr.1962","volume":"28","author":"C Li","year":"2013","unstructured":"Li, C. et al. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH. J. Bone Min. Res. 28, 2094\u20132108 (2013).","journal-title":"J. Bone Min. Res."},{"key":"682_CR229","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/CIRCRESAHA.117.306712","volume":"117","author":"SL Cheng","year":"2015","unstructured":"Cheng, S. L. et al. Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-\/- mice by restraining noncanonical Wnt signals. Circ. Res. 117, 142\u2013156 (2015).","journal-title":"Circ. Res."},{"key":"682_CR230","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/gerona\/glt093","volume":"68","author":"JA Cauley","year":"2013","unstructured":"Cauley, J. A. Public health impact of osteoporosis. J. Gerontol. A Biol. Sci. Med. Sci. 68, 1243\u20131251 (2013).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"682_CR231","unstructured":"American Heart Association. Heart and Stroke Statistics. www.heart.org. https:\/\/www.heart.org\/en\/about-us\/heart-and-stroke-association-statistics (2020)."},{"key":"682_CR232","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/jbmr.3089","volume":"32","author":"N Veronese","year":"2017","unstructured":"Veronese, N. et al. Relationship between low bone mineral density and fractures with incident cardiovascular disease: a systematic review and meta-analysis. J. Bone Min. Res. 32, 1126\u20131135 (2017).","journal-title":"J. Bone Min. Res."},{"key":"682_CR233","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/jbmr.1714","volume":"28","author":"CH Chiang","year":"2013","unstructured":"Chiang, C. H. et al. Hip fracture and risk of acute myocardial infarction: a nationwide study. J. Bone Min. Res. 28, 404\u2013411 (2013).","journal-title":"J. Bone Min. Res."},{"key":"682_CR234","volume":"9","author":"R Zhou","year":"2014","unstructured":"Zhou, R., Zhou, H., Cui, M., Chen, L. & Xu, J. The association between aortic calcification and fracture risk in postmenopausal women in China: the prospective Chongqing osteoporosis study. PLoS One 9, e93882 (2014).","journal-title":"PLoS One"},{"key":"682_CR235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bone.2015.06.019","volume":"81","author":"P Szulc","year":"2015","unstructured":"Szulc, P. et al. Abdominal aortic calcification and risk of fracture among older women \u2014 the SOF study. Bone 81, 16\u201323 (2015).","journal-title":"Bone"},{"key":"682_CR236","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/jbmr.2530","volume":"30","author":"JJ Chan","year":"2015","unstructured":"Chan, J. J. et al. QCT volumetric bone mineral density and vascular and valvular calcification: the Framingham study. J. Bone Min. Res. 30, 1767\u20131774 (2015).","journal-title":"J. Bone Min. Res."},{"key":"682_CR237","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00774-017-0849-0","volume":"36","author":"D Wei","year":"2018","unstructured":"Wei, D., Zheng, G., Gao, Y., Guo, J. & Zhang, T. Abdominal aortic calcification and the risk of bone fractures: a meta-analysis of prospective cohort studies. J. Bone Min. Metab. 36, 439\u2013446 (2018).","journal-title":"J. Bone Min. Metab."},{"key":"682_CR238","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2147\/CIA.S138002","volume":"12","author":"C Caffarelli","year":"2017","unstructured":"Caffarelli, C., Montagnani, A., Nuti, R. & Gonnelli, S. Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies. Clin. Interv. Aging 12, 1819\u20131828 (2017).","journal-title":"Clin. Interv. Aging"},{"key":"682_CR239","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1359\/jbmr.090531","volume":"24","author":"P Szulc","year":"2009","unstructured":"Szulc, P., Samelson, E. J., Kiel, D. P. & Delmas, P. D. Increased bone resorption is associated with increased risk of cardiovascular events in men: the MINOS study. J. Bone Min. Res. 24, 2023\u20132031 (2009).","journal-title":"J. Bone Min. Res."},{"key":"682_CR240","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/jbmr.2905","volume":"31","author":"JA Cauley","year":"2016","unstructured":"Cauley, J. A. et al. Inflammatory markers and the risk of hip and vertebral fractures in men: the osteoporotic fractures in men (MrOS). J. Bone Min. Res. 31, 2129\u20132138 (2016).","journal-title":"J. Bone Min. Res."},{"key":"682_CR241","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/jbmr.2245","volume":"29","author":"KE Barbour","year":"2014","unstructured":"Barbour, K. E. et al. Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fractures. J. Bone Min. Res. 29, 2057\u20132064 (2014).","journal-title":"J. Bone Min. Res."},{"key":"682_CR242","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2015.01.072","volume":"184","author":"HJ Choi","year":"2015","unstructured":"Choi, H. J. et al. Risk of fractures in subjects with antihypertensive medications: a nationwide claim study. Int. J. Cardiol. 184, 62\u201367 (2015).","journal-title":"Int. J. Cardiol."},{"key":"682_CR243","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jbmr.2446","volume":"30","author":"CM Swanson","year":"2015","unstructured":"Swanson, C. M. et al. Obstructive sleep apnea and metabolic bone disease: insights into the relationship between bone and sleep. J. Bone Min. Res. 30, 199\u2013211 (2015).","journal-title":"J. Bone Min. Res."},{"key":"682_CR244","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/jbmr.3619","volume":"34","author":"JA Cauley","year":"2019","unstructured":"Cauley, J. A. et al. Characteristics of self-reported sleep and the risk of falls and fractures: the Women\u2019s Health Initiative (WHI). J. Bone Min. Res. 34, 464\u2013474 (2019).","journal-title":"J. Bone Min. Res."},{"key":"682_CR245","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/jgs.13069","volume":"62","author":"JA Cauley","year":"2014","unstructured":"Cauley, J. A. et al. Hypoxia during sleep and the risk of falls and fractures in older men: the Osteoporotic Fractures in Men Sleep Study. J. Am. Geriatr. Soc. 62, 1853\u20131859 (2014).","journal-title":"J. Am. Geriatr. Soc."},{"key":"682_CR246","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/GME.0000000000000451","volume":"22","author":"SD Sullivan","year":"2015","unstructured":"Sullivan, S. D. et al. Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women\u2019s Health Initiative Observational Study. Menopause 22, 1035\u20131044 (2015).","journal-title":"Menopause"},{"key":"682_CR247","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamacardio.2016.2415","volume":"1","author":"T Muka","year":"2016","unstructured":"Muka, T. et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis. JAMA Cardiol. 1, 767\u2013776 (2016).","journal-title":"JAMA Cardiol."},{"key":"682_CR248","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bone.2008.08.107","volume":"43","author":"P D\u2019Amelio","year":"2008","unstructured":"D\u2019Amelio, P. et al. Role of iron metabolism and oxidative damage in postmenopausal bone loss. Bone 43, 1010\u20131015 (2008).","journal-title":"Bone"},{"key":"682_CR249","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMoa032739","volume":"350","author":"RR McLean","year":"2004","unstructured":"McLean, R. R. et al. Homocysteine as a predictive factor for hip fracture in older persons. N. Engl. J. Med. 350, 2042\u20132049 (2004).","journal-title":"N. Engl. J. Med."},{"key":"682_CR250","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00394-019-01993-8","volume":"59","author":"I Pusceddu","year":"2019","unstructured":"Pusceddu, I. et al. Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study. Eur. J. Nutr. 59, 1399\u20131411 (2019).","journal-title":"Eur. J. Nutr."},{"key":"682_CR251","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2796.2009.02123.x","volume":"266","author":"S Wang","year":"2009","unstructured":"Wang, S. et al. Prevalence and extent of calcification over aorta, coronary and carotid arteries in patients with rheumatoid arthritis. J. Intern. Med. 266, 445\u2013452 (2009).","journal-title":"J. Intern. Med."},{"key":"682_CR252","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.39198","volume":"67","author":"RH Mackey","year":"2015","unstructured":"Mackey, R. H. et al. Rheumatoid arthritis, anti-cyclic citrullinated peptide positivity, and cardiovascular disease risk in the women\u2019s health initiative. Arthritis Rheumatol. 67, 2311\u20132322 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"682_CR253","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41581-021-00513-4","volume":"18","author":"P Singh","year":"2022","unstructured":"Singh, P., Harris, P. C., Sas, D. J. & Lieske, J. C. The genetics of kidney stone disease and nephrocalcinosis. Nat. Rev. Nephrol. 18, 224\u2013240 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"682_CR254","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1681\/ASN.2008070692","volume":"20","author":"M Mizobuchi","year":"2009","unstructured":"Mizobuchi, M., Towler, D. & Slatopolsky, E. Vascular calcification: the killer of patients with chronic kidney disease. J. Am. Soc. Nephrol. 20, 1453\u20131464 (2009).","journal-title":"J. Am. Soc. Nephrol."}],"updated-by":[{"DOI":"10.1038\/s41574-022-00768-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000}}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-022-00682-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-022-00682-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-022-00682-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T02:59:00Z","timestamp":1727233140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-022-00682-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":254,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1038\/s41574-022-00682-7","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41574-022-00768-2","asserted-by":"object"}]},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"assertion":[{"value":"13 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41574-022-00768-2","URL":"https:\/\/doi.org\/10.1038\/s41574-022-00768-2","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.J.A. received consultancy fees from Inositec Inc. in the context of the development of crystallization inhibitors. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}